ClinicalTrials.Veeva
Menu

Find clinical trials for Diabetes in Louisville, KY

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Type 2 Diabetes Mellitus
Diabetes Mellitus
Obesity
Type 1 Diabetes Mellitus
Diabetic Foot
Overweight
Foot Ulcer

Diabetes trials near Louisville, KY, USA:

Janus Kinase (JAK) Inhibitors to Preserve C-Peptide Production in New Onset Type 1 Diabetes (T1D)

control clinical trial testing two different JAK Inhibitors abrocitnib, ritlecitinib, and placebo in subjects with recent onset Stage 3 Type 1 Diabetes...

Active, not recruiting
Diabetes Mellitus, Type 1
Drug: Ritlecitinib
Drug: Abrocitinib 200 MG Oral Tablet

Phase 2

National Institutes of Health (NIH)
National Institutes of Health (NIH)

Louisville, Kentucky, United States and 29 other locations

This study will look at the long-term effects of semaglutide (active medicine) on diabetic eye disease when compared to placebo (dummy medic...

Active, not recruiting
Diabetes Mellitus, Type 2
Drug: Semaglutide
Drug: Placebo (semaglutide)

Phase 3

Novo Nordisk
Novo Nordisk

Louisville, Kentucky, United States and 228 other locations

The purpose of this study is to find out if baricitinib can delay the onset of clinical type 1 diabetes (T1D) in people who are at high risk...

Enrolling
Diabetes Mellitus, Type 1
Drug: Baricitinib
Drug: Placebo

Phase 3

Lilly
Lilly

Louisville, Kentucky, United States and 106 other locations

The main purpose of this study is to evaluate additional dosing options for dulaglutide in pediatric participants with Type 2 Diabetes. Part...

Enrolling
Type 2 Diabetes
Drug: Dulaglutide

Phase 3

Lilly
Lilly

Louisville, Kentucky, United States and 51 other locations

This investigator-initiated study will enroll about 30 adults 18 to 65 years of age with type 1 diabetes (T1D) who are using the Tandem t:sl...

Enrolling
Diabetes Mellitus, Type 1
Device: Control IQ + sleep activity with TI
Jaeb Center for Health Research
Jaeb Center for Health Research

Louisville, Kentucky, United States and 2 other locations

The primary objective of this study is to determine the effects of KAI-9531 administered by subcutaneous (SC) injection once weekly compared to place...

Enrolling
Obesity
Drug: KAI-9531
Drug: Placebo

Phase 2

Kailera

Louisville, Kentucky, United States and 32 other locations

fenofibrate is effective for reducing the onset of proliferative diabetic retinopathy (PDR) or and the results are adopted by the community ...

Enrolling
Diabetic Retinopathy
Other: Placebo
Drug: Fenofibrate

Phase 3

Jaeb Center for Health Research
Jaeb Center for Health Research

New Albany, Indiana, United States and 65 other locations

The study medicine will be investigated in participants with type 1 diabetes. The study will look at how well insulin icodec taken weekly co...

Enrolling
Diabetes Mellitus, Type 1
Drug: Insulin glargine
Drug: Insulin icodec

Phase 3

Novo Nordisk
Novo Nordisk

Louisville, Kentucky, United States and 183 other locations

ezetimibe 10 mg and as monotherapy, on top of guideline-recommended lipid-lowering therapy in patients with metabolic syndrome and/or Type 2 Diabetes...

Enrolling
Type 2 Diabetes (T2DM)
Metabolic Syndrome (MetS)
Drug: Obicetrapib 10 mg
Other: Placebo

Phase 3

NewAmsterdam Pharma

Louisville, Kentucky, United States and 19 other locations

retatrutide dose escalation schemes in participants without type 2 diabetes who have obesity or overweight. Participation in the study will ...

Enrolling
Overweight
Obesity
Drug: Retatrutide

Phase 3

Lilly
Lilly

Louisville, Kentucky, United States and 34 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems